Recursion (RXRX) acquires full rights to oral HPP treatment REV102

Go back to Recursion (RXRX) acquires full rights to oral HPP treatment REV102
(NASDAQ: RLYB) Delayed: 16.38 -0.23 (1.38%)
Previous Close $16.61    52 Week High
Open $16.81    52 Week Low
Day High $16.81    P/E N/A 
Day Low $16.34    EPS
Volume 8,781       

(NASDAQ: RXRX) Delayed: 3.35 +0.06 (1.82%)
Previous Close $3.29    52 Week High
Open $3.32    52 Week Low
Day High $3.42    P/E N/A 
Day Low $3.27    EPS
Volume 11,007,616